Skip to main content
    A

    Anavex Life Sciences Corp (AVXL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.74
    -0.08 (-9.49%)

    Market Cap: $75.79M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Anavex Life Sciences Corp (AVXL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Anavex Life Sciences (AVXL) has a market cap of $75.79M. It holds $118.33M more cash than debt, 156.13% of its market cap. Its share count is up 8.57% from a year earlier.

    Total Valuation

    Market Cap$75.79M
    Latest price (Nov 17, 2026)$0.74

    Key Dates

    The next earnings report is expected on Nov 23, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 23, 2026 (expected)
    Last Earnings DateJul 30, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 0.02% in the quarter ended Jun 30, 2026 and grew 4.72% a year over 2 years.

    Shares Outstanding92.70M
    Shares Change (YoY)+8.57%
    Shares Change (QoQ)+0.02%
    Share Count Growth (2Y CAGR)+4.72%

    Price Statistics

    The stock is down 79.70% over 52 weeks and trades 55.69% below its 50-day average.

    Beta (1Y)2.13
    52-Week Change-79.70%
    1-Month Change-40.80%
    3-Month Change-78.17%
    6-Month Change-72.28%
    5-Year Change-93.65%
    10-Year Change-57.35%
    Total Return (1Y)-79.70%
    Total Return (3Y CAGR)-50.94%
    Total Return (5Y CAGR)-48.37%
    Max Drawdown (1Y)-86.04%
    Max Drawdown (3Y)-94.50%
    Sharpe Ratio (1Y)-1.81
    Correlation with SPY (1Y)0.34
    50-Day Average$1.67
    200-Day Average$2.86
    52-Week Range$0.80 to $5.36
    RSI (14 Days)20.3
    Average Volume (20 Days)1.18M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 15.62x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio15.62x
    Quick Ratio15.62x
    Debt / Equity0.00x
    Interest Coverage4.14x

    Returns and Efficiency

    Return on equity is -11.58% over the last 12 months, against a 5-year average of -35.39%.

    Return on Equity (ROE)-11.58%
    Return on Assets (ROA)-10.84%
    ROE (5Y Average)-35.39%
    ROA (5Y Average)-32.41%
    ROIC (5Y Average)-36.41%

    Scores

    AVXL has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$17.37M
    Pretax Income-$13.00M
    Net Income-$13.02M
    Reported EPS (TTM)-$0.22

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 93.60% of the $120.14M in total assets.

    Cash and Equivalents$118.33M
    Total Debt$0
    Net Cash$118.33M
    Net Cash Per Share$1.28
    Working Capital$112.45M
    Shareholder Equity$112.45M
    Book Value Per Share$1.21
    Total Assets$120.14M
    Total Liabilities$7.69M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$32.66M
    FCF Per Share-$0.35

    Trailing 12 months through Mar 31, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-21.18%
    Tangible Book Per Share Growth (2Y CAGR)-21.18%

    Revenue and profit by year

    Dividends and Yields

    AVXL does not pay a dividend.

    Buyback Yield-66.52%
    Shareholder Yield-66.52%

    Stock Splits

    The last split was a 1-for-4 reverse split on Oct 7, 2015.

    Last Split DateOct 7, 2015
    Split TypeReverse split
    Split Ratio1:4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About AVXL

    What is AVXL's market cap?

    Anavex Life Sciences has a market cap of $75.79M.

    How many shares of AVXL are outstanding?

    Anavex Life Sciences has 92.70M shares outstanding. The count is up 8.57% from a year earlier.

    Does AVXL pay a dividend?

    No. Anavex Life Sciences does not pay a dividend.

    How much debt does AVXL have?

    Anavex Life Sciences has $0 of total debt and $118.33M of cash and equivalents, a net cash position of $118.33M.